{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:48:25Z","timestamp":1789692505715,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012456","name":"Toronto General and Western Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.eplepsyres.2024.107336","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:26:19Z","timestamp":1709396779000},"page":"107336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-9192","authenticated-orcid":false,"given":"Julien","family":"H\u00e9bert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Daniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabber","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-9998","authenticated-orcid":false,"given":"Emily","family":"Thain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-2026","authenticated-orcid":false,"given":"Maria Carolina","family":"Sanabria-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-8674","authenticated-orcid":false,"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-4883","authenticated-orcid":false,"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6855-9669","authenticated-orcid":false,"given":"Aylin Y.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2024.107336_bib1","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.37385","article-title":"Phenotype and genotype of Saudi pediatric patients with neurofibromatosis type 1: a seven-year multicenter experience from Saudi Arabia","author":"Alfurayh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.eplepsyres.2013.02.021","article-title":"Epilepsy surgery in neurofibromatosis type 1","volume":"105","author":"Barba","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.17712\/nsj.2020.5.20200081","article-title":"Clinical spectrum of neurofibromatosis type 1 among children in a tertiary care center","volume":"25","author":"Bashiri","year":"2020","journal-title":"NSJ"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00381-020-04710-7","article-title":"Epilepsy in NF1: a systematic review of the literature","volume":"36","author":"Bernardo","year":"2020","journal-title":"Child Nerv. Syst."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib5","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00381-022-05571-y","article-title":"Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1","volume":"38","author":"Cantor","year":"2022","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.1986.tb48061.x","article-title":"The genetic aspects of neurofibromatosis","volume":"486","author":"Carey","year":"1986","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib7","unstructured":"Chongsuvivatwong, V., 2018. epiDisplay: Epidemiological Data Display Package R package version 3.5.0.1."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/cjn.2017.217","article-title":"Update on minimal standards for electroencephalography in Canada: a review by the Canadian Society of Clinical Neurophysiologists","volume":"44","author":"Dash","year":"2017","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am. J. Med Genet A"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ped.13388","article-title":"Neurological comorbidity in children with neurofibromatosis type 1","volume":"60","author":"Hirabaru","year":"2018","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","article-title":"American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2021 version","volume":"38","author":"Hirsch","year":"2021","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib14","first-page":"1","article-title":"Epilepsy and electroencephalogram characteristics in children with neurofibromatosis type 1, what we have learned from a tertiary center five years\u2019 experience","volume":"9","author":"Khair","year":"2022","journal-title":"Child Neurol. Open"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/cjn.2016.326","article-title":"Neurofibromatosis clinic: a report on patient demographics and evaluation of the clinic","volume":"44","author":"Mansouri","year":"2017","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.12187","article-title":"A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands: a clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics","volume":"85","author":"van Minkelen","year":"2014","journal-title":"Clin. Genet"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Statist. Med."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib19","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/epi.12348","article-title":"Epilepsy in individuals with neurofibromatosis type 1","volume":"54","author":"Ostendorf","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","article-title":"Epilepsy in neurofibromatosis type 1","volume":"73","author":"Pecoraro","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106190","article-title":"Increased seizure susceptibility in a mouse model of neurofibromatosis type 1","volume":"156","author":"Rizwan","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113373","article-title":"Increased epileptogenicity in a mouse model of neurofibromatosis type 1","volume":"331","author":"Sabetghadam","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib25","first-page":"325","article-title":"Manifestaciones neurol\u00f3gicas en neurofibromatosis tipo 1. Nuestra experiencia","volume":"37","author":"S\u00e1nchez Marco","year":"2022","journal-title":"Neurol\u00eda"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib26","article-title":"Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough","volume":"44","author":"Santoro","year":"2018","journal-title":"Ital. J. Pedia"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yebeh.2019.06.022","article-title":"Epilepsy in neurofibromatosis type 1: diffuse cerebral dysfunction","volume":"98","author":"Serdaroglu","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2024.107336_bib28","first-page":"13","article-title":"Epilepsy in NF1: epidemiologic, genetic, and clinical features. A monocentric retrospective study in a cohort of 784 patients","author":"Sorrentino","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.eplepsyres.2024.107336_bib29","unstructured":"Stevenson, M., Sergeant, E., 2023. epiR: Tools for the Analysis of Epidemiological Data R package version 2.0.58."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T23:31:18Z","timestamp":1737847878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":29,"alternative-id":["S0920121124000512"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107336","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107336"}}